Company Filing History:
4 out of 4 
4 out of 4 Years Active: 2023-2025
Title: Shiwei Miao: Innovator in Biopharmaceuticals from Zhejiang, China
Introduction: Shiwei Miao is a prominent inventor based in Zhejiang, China, known for his contributions to biopharmaceutical innovations. With a portfolio of four patents, Miao's work focuses on developing advanced therapeutic proteins aimed at enhancing cancer treatment.
Latest Patents: Miao's latest inventions include significant advancements in the field of oncology. One of his notable patents is for a fusion protein that comprises a first binding domain specifically targeting tumor-associated antigens and a second binding domain that binds a CD47 protein. This fusion protein is designed for use in preparing medicaments and includes immunoconjugates, nucleic acid molecules, vectors, and cells associated with it.
Another critical patent authored by Miao pertains to an antibody binding to the AXL protein. This invention boasts properties such as high specificity for the AXL protein on cell surfaces and the capability to mediate internalization post-binding. The antibody holds promise for constructing immunoconjugates aimed at inhibiting tumor cell proliferation.
Career Highlights: Shiwei Miao has worked with renowned companies in the biotech sector, including Hangzhou Sumgen Biotech Co., Ltd. and Sumgen MAB (Beijing) Biotech Co., Ltd. His work in these companies has allowed him to explore innovative therapeutic avenues, contributing significantly to the field of biopharmaceuticals.
Collaborations: Throughout his career, Miao has collaborated with talented individuals such as Ming Lv and Xiaoran Ding. These partnerships have fostered a creative and productive environment for research and development, driving forward the progress of biopharmaceutical innovations.
Conclusion: As an inventor with a focus on groundbreaking biopharmaceutical solutions, Shiwei Miao continues to make strides in the healthcare sector. His innovative patents contribute valuable tools in the fight against cancer, demonstrating the importance of collaboration and creativity in advancing medical research.